Search Results

You searched for : Mounjaro  

The Weight-Loss Injection Illusion: What Happens When the Miracle Jabs Stop Working?

Medical innovation has provided powerful tools to address one of the world’s most pressing health challenges. But the path to lasting wellness still requires ...
Mar 07

Are GLP-1 Weight Loss Drugs Enough to Prevent Heart Attack and Stroke?

The debate between pharmacotherapy and surgery will continue, but patients deserve nuanced guidance grounded in evidence, not trends...
Feb 26

A ₹100-Crore Question: Are GLP-1 Injections Becoming India’s New Lifeline?

The obesity epidemic is vast. The solutions are emerging. Science is evolving. And the market is expanding. The launch of Yurpeak is another step in ...
Dec 12

When the Weight-Loss Journey Collides With Pregnancy: The Hidden Story Behind GLP-1 Drugs and Women’s Health

As more women use these medications globally and as research expands, the world will gain a clearer picture of how these powerful drugs shape reproductive ...
Nov 26

The Slimmer Price War: How Wegovy’s Price Slash Signals a New Era in India’s Weight-Loss Drug Market

As the patent clock ticks towards 2026, both Novo and Lilly are likely to intensify their efforts in expanding supply chains, boosting physician engagement, and ...
Nov 14

Credibility Meets Convenience: India’s GLP-1 Battleground Gets a KwikPen Revolution

Long-term effects of GLP-1 medications remain under investigation, and shifting to easy-to-use pens removes barriers but not risks....
Aug 16

Can India’s Generics Take the Centre Stage and End Weight-Loss Monopoly

Generic semaglutide could ultimately become not just an alternative, but the new standard driven by precision manufacturing, scaled access, and cost redefined....
Aug 11

Lilly’s Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease

Mounjaro met the primary objective of non-inferiority vs. Trulicity with an 8% lower rate of MACE-3 events, while delivering greater reductions in A1C ...
Aug 01

India’s Weight Loss Gamble: Will GLP‑1 Drugs Reshape the Health of a Nation?

India is stepping into a new phase of healthcare where the battle against obesity is no longer limited to gym memberships or diet fads....
Aug 01

Wegovy Lands in India: Miracle Weight Loss Shot or Medical Marketing Hype?

As India confronts an alarming rise in obesity and related conditions like type 2 diabetes, cardiovascular disease, and polycystic ovarian syndrome, the spotlight on medical ...
Jun 25

Mounjaro (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine

...
May 12

Ozempic, Mounjaro, and the Weight Loss Drug Revolution: What Patients Need to Know

A somewhat promising era of weight management has arrived. Ozempic and Mounjaro are no longer just for diabetes. But it’s not all magic. Risks, ...
May 10

Lilly Launches Mounjaro® (tirzepatide), offering a new option for the treatment of obesity and type 2 diabetes

...
Mar 20

Is Ozempic Truly A ‘Miracle Drug’ For Weight Loss? Understanding The Safety and Effectiveness Concerns

Ozempic is not officially available in India and is not approved for use in India. While the demand for Ozempic is high, the supply is ...
Jan 23

Cipla Eyes Eli Lilly Partnership to Tap Growing Demand for Obesity Drugs in India

In response to the market demand, Indian drugmakers, including Cipla, are actively developing generic versions of these weight-loss drugs to secure a larger market ...
May 13

Biocon Ventures into Weight-Loss Drug Market with Semaglutide Development

Biocon's foray into the weight-loss drug market aligns with its significant investment in generics research and development, with a notable focus on peptides ...
Apr 20

FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly

As the medication becomes available, its impact on individuals suffering from obesity and related conditions is eagerly anticipated. However, the pricing challenges highlight the need ...
Nov 17

17 Matching result(s) found!

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026